Treatment of herpes simplex
Patent 4424232 Issued on January 3, 1984. Estimated Expiration Date: 
May 19, 2002. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
May 19, 2002. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesMedication for herpes simplex and canker sores Nonionic surface active anti-viral agents Treatment for herpes virus Patent #: 4285934 InventorApplicationNo. 06/379737 filed on 05/19/1982US Classes:514/468, Polycyclo ring system having the hetero ring as one of the cyclos514/474, Ascorbic acid or derivative (e.g., vitamin C, etc.)514/564, Plural nitrogens nonionically bonded514/588, Ureas (i.e., N-C(=O)-N)514/928, Topical514/934VirusExaminersPrimary: Schenkman, LeonardAttorney, Agent or FirmInternational ClassesA61K 31/185 (20060101)A61K 31/195 (20060101) A61K 31/375 (20060101) AbstractHerpes simplex, cold sores, lesions, warts, blisters, burns, ulcers, and other painful skin conditions are treated by topical application of a composition comprising L-lysine, gibberellic acid, and urea in an inert carrier comprising water. The composition can additionally contain L-ascorbic acid, and a member selected from the group consisting of methyl paraben, propyl paraben, and mixtures thereof.Other References
| |
